Fibromuscular dysplasia natural history, complications and prognosis: Difference between revisions
No edit summary |
|||
| Line 17: | Line 17: | ||
===Natural History=== | ===Natural History=== | ||
Fibromuscular dysplasia can involve virtually every artery of the body, thus the clinical presentations of FMD vary widely and are determined by the vessels territories that are involved. in the FMD Multivessel involvement is common,too | |||
The clinical presentations may result from the stenosis, ischemia, dissection and occlusion,rupture of aneurysms and embolization of intravascular thrombi from dissection or aneurysms.<ref>{{Cite journal | |||
| author = [[Jeffrey W. Olin]] & [[Brett A. Sealove]] | |||
| title = Diagnosis, management, and future developments of fibromuscular dysplasia | |||
| journal = [[Journal of vascular surgery]] | |||
| volume = 53 | |||
| issue = 3 | |||
| pages = 826–836 | |||
| year = 2011 | |||
| month = March | |||
| doi = 10.1016/j.jvs.2010.10.066 | |||
| pmid = 021236620 | |||
}}</ref> | |||
===Complications=== | ===Complications=== | ||
Revision as of 01:19, 13 June 2018
|
Fibromuscular dysplasia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
ASA/ACCF/AHA Guideline Recommendations |
|
Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries |
|
Case Studies |
|
Fibromuscular dysplasia natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Fibromuscular dysplasia natural history, complications and prognosis |
|
FDA on Fibromuscular dysplasia natural history, complications and prognosis |
|
CDC on Fibromuscular dysplasia natural history, complications and prognosis |
|
Fibromuscular dysplasia natural history, complications and prognosis in the news |
|
Blogs on Fibromuscular dysplasia natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
Fibromuscular dysplasia can involve virtually every artery of the body, thus the clinical presentations of FMD vary widely and are determined by the vessels territories that are involved. in the FMD Multivessel involvement is common,too The clinical presentations may result from the stenosis, ischemia, dissection and occlusion,rupture of aneurysms and embolization of intravascular thrombi from dissection or aneurysms.[1]
Complications
- Common complications of [disease name] include:
- [Complication 1]
- [Complication 2]
- [Complication 3]
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
- Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
References
- ↑ Jeffrey W. Olin & Brett A. Sealove (2011). "Diagnosis, management, and future developments of fibromuscular dysplasia". Journal of vascular surgery. 53 (3): 826–836. doi:10.1016/j.jvs.2010.10.066. PMID 021236620. Unknown parameter
|month=ignored (help)